St. Gallen, Switzerland

Helena Derksen

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Schott Pharma Schweiz Ag. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Helena Derksen: Innovator in Syringe Technology

Introduction

Helena Derksen is a notable inventor based in St. Gallen, Switzerland. She has made significant contributions to the field of medical devices, particularly in syringe technology. Her innovative approach has led to the development of a unique syringe design that incorporates different materials for enhanced functionality.

Latest Patents

Helena holds a patent for a syringe that includes a syringe body, a syringe cone with a distal opening, and a connection arranged in the region of the syringe cone. The syringe body is made from a first material, while the connection is crafted from a second, softer material. This design allows for improved usability and safety in medical applications.

Career Highlights

Throughout her career, Helena has worked with prominent companies in the pharmaceutical industry, including Schott Pharma Schweiz AG and Schott AG. Her experience in these organizations has provided her with valuable insights into the needs and challenges of medical device development.

Collaborations

Helena has collaborated with talented professionals in her field, including Judith Auerbach and Bastian Fischer. These partnerships have contributed to her innovative projects and have fostered a collaborative environment for advancing medical technology.

Conclusion

Helena Derksen's contributions to syringe technology exemplify her commitment to innovation in the medical field. Her work continues to impact the industry positively, paving the way for safer and more effective medical devices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…